You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. AFFINITY PURIFICATION OF PARAINFLUENZA VIRUS GLYCOPROTEINS

    SBC: MOLECULAR ENGINEERING CORP.            Topic: N/A

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  2. A multiscale computational tool to simulate the PK of orally-administered drugs in the human GI tract

    SBC: CFD RESEARCH CORPORATION            Topic: 400

    A multiscale computational tool to simulate the PK of orally administered drugs in the human GI tract Project Summary AbstractMost FDA approved drugs are administered orallydespite the complex process of oral drug absorption that is difficult to analyze experimentallyOral bioavailability is dependent on the interplay between multiple and simultaneous processes that are dependent on both the drug c ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  3. A novel biomarker of infection in neutropenic cancer patients

    SBC: BIOPOWERTECH            Topic: NIAID

    DESCRIPTION provided by applicant Early diagnosis of an infection in neutropenic cancer patients is critical for timely treatment But the diagnosis of an infection in these patients especially at an early stage can be very challenging Therefore there is a great need for sensitive biomarkers that can rapidly predict an infection and provide possible outcomes We have already reported that s ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. A novel phosphodiesterase isozyme target and class of inhibitors for lung cancer

    SBC: ADT Pharmaceuticals, LLC            Topic: 102

    DESCRIPTION provided by applicant Lung cancer causes more deaths in men and women than any other cancer in the United States Late detection of disease and inability to effectively treat this malignancy with chemotherapy are the main reasons for low survival rates There is an urgent medical need to develop new molecularly targeted drugs for treating lung cancer although it has been challengin ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  5. A Portable Device for Accurate Mouse Tail Vein Injection

    SBC: Technology Commercialization Partners LLC            Topic: OD

    PROJECT SUMMARYABSTRACT To datethe standard method to access a mouse tail vein is manual injectionbut its yield rate is poor in generalThis leads to multiple needle insertions associated with tissue damage and painBesidesfailure in tail vein injection leads to data lossand thereby more animals will be required to compensate itFinallythe dose variation induced by unreliable injection increases erro ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  6. A single dose long-acting non-addictive polymer conjugate formulation of buprenorphine that provides immediate and prolonged analgesia for post-operative pain

    SBC: SERINA THERAPEUTICS INC            Topic: NINDS

    PAProject Summary Abstract SERis a long acting polymer pro drug of buprenorphine that is being developed to treat postoperative pain following major surgeries such as bunionectomyabdominoplastythoracotomy and knee and hip surgerySERhas no biological activity by itselfbut when administered in vivo by subcutaneous injection it enters the vascular compartment where a plasma esterasebutyrylcholinester ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Automated Rodent Research Home Cage Monitoring System for Animal Welfare

    SBC: TRICORDER ARRAY TECHNOLOGIES LLC            Topic: 100

    PROJECT SUMMARY The for profit small business concernTricorder Array Technologies LLCwill developin partnership with the University of Alabama at BirminghamSIDECAReSensing and Integrating Data for Environmental Conditions in Animal ResearchThis device will automate collection of relevant data that will enhance consistency in animal models used to study human health treatment researchOur innovative ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Bionanomatrix coating for brain aneurysm coils to enhance healing

    SBC: ENDOMIMETICS LLC            Topic: 105

    DESCRIPTION provided by applicant More than of the population has unruptured cerebral aneurysms approximately million people in the US About rupture per year with devastating consequences More than of patients with ruptured aneurysms die and of who survive have significant disabilities Detachable microcoils are now used in more than of treated aneurysms The risk ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Critical Program Information (CPI) Identification and Assessment Tool

    SBC: Management Analysis Network, LLC, The            Topic: SCO183002

    Protecting the effectiveness of US advanced weapon systems and the technology they rely on is a national priority. Unfortunately, individuals tasked with this mission are met with disjointed guidance, no training, and competing processes to consider. It is no wonder adversaries continue to exploit these weaknesses in the Department of Defense (DOD); stealing our Critical Program Information (CPI) ...

    SBIR Phase I 2019 Department of DefenseOffice of the Secretary of Defense
  10. Development and Validation of a Novel Biomarker Assay for Cancer Diagnostics

    SBC: Blondin Bioscience, LLC            Topic: 100

    DESCRIPTION provided by applicant In this Phase I project Blondin Bioscience LLC a start up company in Birmingham AL proposes to develop a rapid accurate and precise fluorometric assay for quantifying cell free telomeric DNA fragments cf tDNA within serum in order to monitor the effectiveness of chemotherapy treatments In our preliminary work conducted at the University of Alabama at ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government